These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31471752)

  • 1. Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).
    Moche M; Busse H; Futterer JJ; Hinestrosa CA; Seider D; Brandmaier P; Kolesnik M; Jenniskens S; Blanco Sequeiros R; Komar G; Pollari M; Eibisberger M; Portugaller HR; Voglreiter P; Flanagan R; Mariappan P; Reinhardt M
    Eur Radiol; 2020 Feb; 30(2):934-942. PubMed ID: 31471752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
    Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
    J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT).
    Reinhardt M; Brandmaier P; Seider D; Kolesnik M; Jenniskens S; Sequeiros RB; Eibisberger M; Voglreiter P; Flanagan R; Mariappan P; Busse H; Moche M;
    Contemp Clin Trials Commun; 2017 Dec; 8():25-32. PubMed ID: 29696193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Software-based planning of ultrasound and CT-guided percutaneous radiofrequency ablation in hepatic tumors.
    van Amerongen MJ; Mariappan P; Voglreiter P; Flanagan R; Jenniskens SFM; Pollari M; Kolesnik M; Moche M; Fütterer JJ
    Int J Comput Assist Radiol Surg; 2021 Jun; 16(6):1051-1057. PubMed ID: 33974224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
    Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
    AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of hepatocellular carcinoma guided by real-time physics-based ablation simulation: a prospective study.
    Hoffer EK; Drinane MC; Bhatnagar V; Mehta R; Munger DP; Borsic A
    Int J Hyperthermia; 2024; 41(1):2331704. PubMed ID: 38503326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
    El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome.
    Mitani H; Naito A; Chosa K; Kodama H; Sumida M; Moriya T; Awai K
    Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):894-901. PubMed ID: 34726557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
    Heerink WJ; Solouki AM; Vliegenthart R; Ruiter SJS; Sieders E; Oudkerk M; de Jong KP
    Eur Radiol; 2018 Aug; 28(8):3228-3236. PubMed ID: 29536242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience.
    Marquez HP; Puippe G; Mathew RP; Alkadhi H; Pfammatter T; Fischer MA
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):90-98. PubMed ID: 27812781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value or waste: Perfusion imaging following radiofrequency ablation - early experience.
    Thieme SF; Vahldiek JL; Tummler K; Poch F; Gemeinhardt O; Hiebl B; Lehmann KS; Hamm B; Niehues SM
    Clin Hemorheol Microcirc; 2015; 61(2):323-31. PubMed ID: 26410879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
    Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
    Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D CACT-assisted Radiofrequency Ablation Following Transarterial Chemoembolization for Hepatocellular Carcinoma: Early Experience.
    Jiao DC; Han XW; Wu G; Ren JZ
    Asian Pac J Cancer Prev; 2015; 16(17):7897-903. PubMed ID: 26625818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
    Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.